CIK 0001706431 · Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 812730369
- Phone
- 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,939
- in 1 filing, $42K under 10b5-1 plans
Net −$41,939. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-10-10 | SATO VICKI L Director | Grant or award · Stock Option (Right to Buy) | +22,222 | 22,222 | ||
| 2019-10-10 | Horn Howard CFO | Grant or award · Stock Option (Right to Buy) | +111,111 | 111,111 | ||
| 2019-10-10 | PEREZ ROBERT J Director | Grant or award · Stock Option (Right to Buy) | +22,222 | 22,222 | ||
| 2019-01-16 | Alaska Permanent Fund Corp 10% owner | Conversion · Series B convertible preferred stock | −1,111,111 | 0 |
Page 61 of 61 · 1,204 trades